GOBBI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 1.838
AS - Asia 1.512
EU - Europa 1.185
SA - Sud America 151
AF - Africa 87
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 4.788
Nazione #
US - Stati Uniti d'America 1.808
CN - Cina 749
SG - Singapore 340
IE - Irlanda 276
FI - Finlandia 163
HK - Hong Kong 160
UA - Ucraina 149
RU - Federazione Russa 147
DE - Germania 133
VN - Vietnam 124
BR - Brasile 109
SE - Svezia 81
FR - Francia 60
ZA - Sudafrica 59
GB - Regno Unito 57
IT - Italia 48
IN - India 43
AR - Argentina 18
CA - Canada 18
BE - Belgio 14
TR - Turchia 13
PL - Polonia 12
BD - Bangladesh 11
JP - Giappone 10
CZ - Repubblica Ceca 9
MA - Marocco 8
MX - Messico 8
CO - Colombia 7
NL - Olanda 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
EC - Ecuador 6
EU - Europa 6
IQ - Iraq 6
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AT - Austria 4
EG - Egitto 4
ET - Etiopia 4
KE - Kenya 4
PH - Filippine 4
VE - Venezuela 4
ES - Italia 3
GE - Georgia 3
GR - Grecia 3
ID - Indonesia 3
JO - Giordania 3
LB - Libano 3
MK - Macedonia 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
CH - Svizzera 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
IL - Israele 1
KZ - Kazakistan 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.788
Città #
Chandler 298
Dublin 275
Jacksonville 215
Singapore 193
Nanjing 178
Hong Kong 157
Ashburn 144
Beijing 130
San Jose 129
Dallas 103
Boardman 74
Nanchang 70
Ann Arbor 59
Johannesburg 54
Lawrence 49
Princeton 49
Los Angeles 47
Wilmington 46
Hebei 45
Helsinki 43
Lauterbourg 43
Ho Chi Minh City 42
Jiaxing 40
Medford 40
Shenyang 39
Changsha 37
New York 35
Hanoi 32
Munich 30
Turku 29
Hangzhou 25
Buffalo 24
Moscow 24
Tianjin 24
Shanghai 17
Brussels 14
Chennai 14
Des Moines 13
Redondo Beach 12
Seattle 12
Warsaw 12
Milan 11
Woodbridge 11
Da Nang 10
London 10
Guangzhou 9
Tokyo 9
Brno 8
Norwalk 8
Fairfield 7
Frankfurt am Main 7
Orem 7
Santa Clara 7
São Paulo 7
The Dalles 7
Boston 6
Brooklyn 6
Houston 6
Kunming 6
Montreal 6
Pavia 6
San Francisco 6
Stockholm 6
Tashkent 6
Atlanta 5
Chicago 5
Haiphong 5
Quito 5
Santa Fe 5
St Petersburg 5
Toronto 5
Verona 5
Addis Ababa 4
Amsterdam 4
Mexico City 4
Salvador 4
San Genesio Ed Uniti 4
Stamford 4
Amman 3
Andover 3
Ankara 3
Belo Horizonte 3
Biên Hòa 3
Brasília 3
Cambridge 3
Carapicuíba 3
Falkenstein 3
Fes 3
Fortaleza 3
Haikou 3
Jinan 3
João Pessoa 3
Manchester 3
Mumbai 3
Ningbo 3
Nuremberg 3
Orange 3
Phoenix 3
Riyadh 3
Secaucus 3
Totale 3.218
Nome #
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. 144
Chemoresistance as a function of the pre-therapy tumor burden and the chemotherapy regimen administered. Differences observed with two current chemotherapy regimens for advanced Hodgkin lymphoma 140
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system 136
Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy 129
[Idiopathic myelodysplastic syndromes. A caseload contribution]. 122
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 122
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 121
International prognostic scoring system for Waldenstrom macroglobulinemia 120
Tumor burden at diagnosis is the main clinical predictor of cell resistance in patients with early-stage, favorable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapy. 120
New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer. 118
Bortezomib-induced paralytic ileus is a potential gastrointestinal side-effect of this first-in-class anti-cancer proteasome inhibitor 116
Erratum to: Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study (Intern Emerg Med, (2014), 9, (861-870), DOI 10.1007/s11739-014-1096-1) 116
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. 115
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 114
The prognosis of patients with liver metastases from colorectal cancer still depends on anatomical presentation more than on treatments 110
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 107
Pamidronate versus observation in asymptomatic myeloma: final results with long follow-up of a randomized study 107
Improving the AJCC/TNM Classification for use in early gastric cancer 104
Basic and acidic isoferritins in the serum of patients with Hodgkin's disease. 103
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 103
Metabolic tumour volumes measured at staging in lymphoma: Methodological evaluation on phantom experiments and patients 102
R-CHOP vs. R-mini-CEOP for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma. Results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi (IIL). 102
Prognostic validation of the international classification of immunoglobulin M gammopathies: A survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance? 102
Chronic granulocytic leukemia. A retrospective study of 91 cases. I. Hemogram at diagnosis and research of prognostic factors. 101
How I treat enteropathy-associated T-cell lymphoma 100
Long-term follow-up of Crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells 98
International prognostic scoring system for Waldenstrom macroglobulinemia. 98
Changing clinical presentation of multiple myeloma. 97
Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in- class anticancer proteasome inhibitor. 96
Tumor burden predicts treatment resistance in patients with early unfavorable or advanced-stage Hodgkin Lymphoma treated with ABVD and radiotherapy. 95
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters 94
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 94
Tumor burden in Hodgkin’s lymphoma: much more than the best prognostic factor. 93
Hodgkin lymphoma. 92
What has happened to VBM (vinblastine, bleomycin and methotrexate) chemotherapy for early-stage Hodgkin lymphoma ? 90
Long-term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with ProMECE-CytaBOM plus involved-field radiation therapy: a study of the Gruppo Italiano Studio Linfomi. 89
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 89
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 85
Long-term follow-up analysis of HD9601 trial comparing ABVD vs. Stanford V vs. MOPPEBVCAD in patients with newly diagnosed advanced-stage Hodgkin lymphoma. A study from the Intergruppo Italiano Linfomi (IIL). 83
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. 81
Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. 80
Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma. 78
The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer 72
Prognostic factors in symptomatic Waldenstrom's macroglobulinemia 69
Reed-Sternberg cell leukaemia. 68
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility 61
Low incidence but poor prognosis of complicated coeliac disease in four Italian centres. 60
Natural history of idiopathic refractory sideroblastic anemia. 59
Prognostic factors in non-Hodgkin's lymphomas 50
Totale 4.845
Categoria #
all - tutte 19.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.036


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 0 51 40 10
2021/2022240 5 3 2 4 7 2 6 15 6 11 40 139
2022/2023790 76 76 9 67 81 76 2 56 316 6 16 9
2023/2024235 44 39 10 17 19 56 3 28 1 5 4 9
2024/2025682 33 51 20 16 25 19 39 32 178 19 80 170
2025/20261.518 100 82 166 200 221 60 321 99 147 122 0 0
Totale 4.845